Insulin-like growth factor 1 receptor messenger RNA 3' untranslated region (IGF-1R mRNA 3'UTR)

The Insulin-like growth factor 1 receptor (IGF-1R) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment that governs the expression of the IGF-1R protein through post-transcriptional mechanisms. This region contains multiple evolutionary conserved binding sites for microRNAs (miRNAs) and RNA-binding proteins, which collectively modulate mRNA stability and translational efficiency (La Rocca et al., 2009). In various cancers, including breast, colorectal, and glioblastoma, the IGF-1R pathway is frequently overactivated, driving tumor growth, survival, and resistance to therapy (Pollak, 2008). Therapeutic strategies targeting the 3'UTR, such as miRNA mimics (e.g., miR-145 or miR-7 mimics) and antisense oligonucleotides (ASOs), aim to reduce IGF-1R protein levels by inducing mRNA degradation or blocking translation (Jiang et al., 2010). This approach provides a highly specific method for downregulating the IGF-1 signaling axis, potentially overcoming the limitations and toxicity associated with small molecule inhibitors or monoclonal antibodies targeting the receptor protein itself (Werner & Bruchim, 2009).

Other names

IGF1R 3'UTRIGF-1 receptor 3' untranslated regionInsulin-like growth factor 1 receptor 3'UTR

The primary mechanism of action involves the sequence-specific binding of antisense oligonucleotides or microRNA mimics to the 3'UTR, which triggers the recruitment of the RNA-induced silencing complex (RISC) or other nucleases, leading to mRNA cleavage, degradation, or the physical blocking of the translational machinery.